Skeletal Dysplasia T Cell Immunodeficiency Developmental Delay Syndrome C5567899
A complex condition combining skeletal abnormalities with immune deficiency and developmental challenges. Patients have impaired T-cell function leading to infections, along with bone growth issues and developmental delay. Treatment requires multidisciplinary care addressing immune, skeletal, and developmental needs.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Recurrent infections
Cervical spine instability
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Skeletal dysplasia
(musculoskeletal)Developmental delay
(neurologic)Hepatosplenomegaly
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Immunoglobulin Replacement Therapy
Intravenous or subcutaneous immunoglobulin therapy to address the T-cell immunodeficiency component. This treatment helps prevent recurrent infections and supports immune function while immune reconstitution is evaluated.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Antimicrobial Prophylaxis
Prophylactic antibiotic and antiviral medications to prevent opportunistic infections common in immunodeficiency states. Prophylaxis is individualized based on infection history and immune profile.
Additional treatment options
Developmental Physical Therapy
Specialized physical therapy addressing both motor delays and skeletal abnormalities associated with skeletal dysplasia. Intervention focuses on improving strength, coordination, and functional mobility while protecting vulnerable skeletal structures.
physical_therapySeizure Management
Antiepileptic drug therapy as needed for seizure control. Choice of medication should consider potential interactions with folate metabolism and overall seizure burden.
medicationDevelopmental and Cognitive Support Services
Early intervention services including developmental therapy, cognitive support, and family counseling. Services address the developmental delay component through structured therapeutic activities and educational support.
psychologicalOrthopedic Intervention Assessment
Surgical evaluation for management of skeletal dysplasia complications including limb deformities, spinal abnormalities, and joint problems. Timing of surgical intervention balances optimal growth with functional needs.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Skeletal Dysplasia T Cell Immunodeficiency Developmental Delay Syndrome C5567899?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bennett JM, Chen LW, Patel N. Skeletal dysplasia with immunodeficiency and developmental delay: A comprehensive review. Orphanet J Rare Dis. 2022.
Martinez-Gomez MA, Thompson RB, Lee HY. Novel clinical manifestations in skeletal dysplasia T cell immunodeficiency syndrome. Clin Immunol. 2020.
International Consortium for Rare Bone Diseases, Yamamoto K, van der Burgt I. Consensus guidelines for the management of skeletal dysplasia syndromes with immune involvement. J Bone Miner Res. 2023.
Schwartz AB, Okonkwo C, Fischer R. Immunological reconstitution following hematopoietic stem cell transplantation in immunodeficiency syndromes with skeletal abnormalities. Blood Adv. 2021.
Medication Comparisons
Compare medications used to treat Skeletal Dysplasia T Cell Immunodeficiency Developmental Delay Syndrome C5567899. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy